Atrial fibrillation surgical ablation: Difference between revisions

	Atrial Fibrillation Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atrial Fibrillation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Special Groups Postoperative AF Acute Myocardial Infarction Wolff-Parkinson-White Preexcitation Syndrome Hypertrophic Cardiomyopathy Hyperthyroidism Pulmonary Diseases Pregnancy ACS and/or PCI or valve intervention Heart failure
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram EKG Examples A-Fib with LBBB
Chest X Ray
Echocardiography
Holter Monitoring and Exercise Stress Testing
Cardiac MRI
Treatment
Rate and Rhythm Control
Cardioversion Overview Electrical Cardioversion Pharmacological Cardioversion
Anticoagulation Overview Warfarin Converting from or to Warfarin Converting from or to Parenteral Anticoagulants Dabigatran
Maintenance of Sinus Rhythm
Surgery Catheter Ablation AV Nodal Ablation Surgical Ablation Cardiac Surgery
Specific Patient Groups
Primary Prevention
Secondary Prevention
Supportive Trial Data
Cost-Effectiveness of Therapy
Case Studies
Case #1
Atrial fibrillation surgical ablation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atrial fibrillation surgical ablation
CDC on Atrial fibrillation surgical ablation
Atrial fibrillation surgical ablation in the news
Blogs on Atrial fibrillation surgical ablation
Directions to Hospitals Treating Atrial fibrillation surgical ablation
Risk calculators and risk factors for Atrial fibrillation surgical ablation

VisualWikitext

Latest revision as of 19:55, 1 December 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Anahita Deylamsalehi, M.D.[3] Vendhan Ramanujam M.B.B.S [4]

Synonyms and keywords: Cox-Maze, Cox Maze, Maze, Minimaze, Mini Maze, Mini-Maze, Cox maze procedure, Maze procedure, Minimaze procedure

Overview

The Maze procedure is a surgical treatment option for some patients with atrial fibrillation. In this procedure, a series of incisions in a cross-like pattern is made on the atria, which blocks the abnormal atria circuits, hence eliminating the atrial fibrillation. A number of improvements have been made to this surgical procedure since it was first invented. Recently, various methods of minimally invasive maze procedures have been developed; these procedures are collectively named minimaze, mini versions of the original maze surgery.

Indications for Catheter and Surgical Ablation

Ablation of atrial fibrillation is recommended in the presence of symptomatic atrial fibrillation, which is refractory or intolerant to at least one class I or III antiarrhythmic medication. The indications are stratified as class I, class IIa, class IIb, and class III.^[1]

Class I Indications

In symptomatic paroxysmal atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, catheter ablation is recommended.^[2]

Class IIa Indications

In symptomatic persistent atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, catheter ablation is reasonable.^[2]
In symptomatic paroxysmal atrial fibrillation patients, prior to initiation of antiarrhythmic drug therapy with either class I or III antiarrhythmic agent, catheter ablation is reasonable.^[2]
In patients who are undergoing surgery for other indications with symptomatic paroxysmal atrial fibrillation, refractory or intolerant to at least one class I or III antiarrhythmic medication, surgical ablation is reasonable.^[2]
In patients who are undergoing surgery for other indications with symptomatic persistent atrial fibrillation, refractory or intolerant to at least one class I or III antiarrhythmic drug, surgical ablation is reasonable.^[2]
In patients who are undergoing surgery for other indications with symptomatic longstanding persistent atrial fibrillation, refractory or intolerant to at least one class I or III antiarrhythmic drug, surgical ablation is reasonable.^[2]
In patients who are undergoing surgery for other indications with symptomatic paroxysmal atrial fibrillation prior to initiation of antiarrhythmic drug therapy with either class I or III antiarrhythmic drug, surgical ablation is reasonable.^[2]
In patients who are undergoing surgery for other indications with symptomatic persistent atrial fibrillation prior to initiation of antiarrhythmic drug therapy with either class I or III antiarrhythmic agent, surgical ablation is reasonable.^[2]

Class IIb Indications

In symptomatic longstanding persistent atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic agent, catheter ablation may be considered.^[3]
In patients with symptomatic persistent atrial fibrillation prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic medication, catheter ablation may be considered.
In patients with symptomatic longstanding persistent atrial fibrillation prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic medication, catheter ablation may be considered.^[3]
In patients who are undergoing surgery for other indications with symptomatic longstanding persistent atrial fibrillation prior to initiation of antiarrhythmic drug therapy with a [[[Antiarrhythmic agent|class I or III antiarrhythmic agent]], surgical ablation may be considered.
In symptomatic paroxysmal atrial fibrillation patients who are either refractory or intolerant to at least one [[class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have not failed catheter ablation but prefer a surgical approach.
In symptomatic paroxysmal atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have failed one or more attempts at catheter ablation.
In symptomatic persistent atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have not failed catheter ablation but prefer a surgical approach.
In symptomatic persistent atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have failed one or more attempts at catheter ablation.
In symptomatic longstanding persistent atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have not failed catheter ablation but prefer a surgical approach.
In symptomatic longstanding persistent atrial fibrillation patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have failed one or more attempts at catheter ablation.

Class III Indications

In symptomatic paroxysmal or persistent or longstanding persistent atrial fibrillation patients, prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic agent, stand alone surgical ablation is not recommended.^[3]

Surgical Ablation

Cox Maze Procedure

James Cox, MD, and associates developed the "Maze" or "Cox Maze" procedure, an "open-heart" cardiac surgery procedure intended to eliminate atrial fibrillation, and performed the first one in 1987.^[4]
Maze refers to the series of incisions arranged in a maze-like pattern in the atria.^[5]
The intention was to eliminate atrial fibrillation by using incisional scars to block abnormal electrical circuits (atrial macroreentry) that atrial fibrillation requires.^[5]
This required an extensive series of endocardial (from the inside of the heart) incisions through both atria, a median sternotomy (vertical incision through the sternum) and cardiopulmonary bypass (heart-lung machine; extracorporeal circulation).
A series of improvements were made, culminating in 1992 in the Cox Maze III procedure, which is now considered to be the "gold standard” for effective surgical cure of atrial fibrillation.^[4]
It was quite successful in eliminating atrial fibrillation, but had drawbacks as well.^[6]
The Cox Maze III is sometimes referred to as the “Traditional Maze”, the “cut and sew Maze”, or simply the "Maze".
Efforts have since been made to equal the success of the Cox Maze III while reducing surgical complexity and the likelihood of complications. During the late 1990s, operations similar to the Cox-Maze, but with fewer atrial incisions, led to the use of the terms "Minimaze", "Mini Maze" and “Mini-Maze”, although these were still major operations.^[7]
A primary goal has been to perform a curative, "Maze-like" procedure, epicardially (from the outside of the heart), so that it could be performed on a normally beating heart, without cardiopulmonary bypass. Until recently this was not thought possible; as recently as 2004, Dr. Cox defined the Mini-Maze as requiring an endocardial approach:

“In summary, it would appear that placing the following lesions can cure most patients with atrial fibrillation of either type: pulmonary vein encircling incision, left atrial isthmus lesion with its attendant coronary sinus lesion, and the right atrial isthmus lesion. We call this pattern of atrial lesions the “Mini-Maze Procedure” … None of the present energy sources—including cryotherapy, unipolar radiofrequency, irrigated radiofrequency, bipolar radiofrequency, microwave, and laser energy—are capable of creating the left atrial isthmus lesion from the epicardial surface, because of the necessity of penetrating through the circumflex coronary artery to reach the left atrial wall near the posterior mitral annulus. Therefore, the Mini-Maze procedure cannot be performed epicardially by means of any presently available energy source.”^[8]

Minimally Invasive Epicardial Surgical Procedures

Despite its efficacy, the Cox-Maze procedure did not gain widespread application due to its complexity, technical difficulty, and risks. In an attempt to simplify the operation and make it more accessible, the incisions of the traditional cut-and-sew Cox-Maze procedure has been replaced with linear lines of ablation. They are called minimaze surgeries.^[9]
These procedures are less invasive than the Cox-Maze procedure and do not require a median sternotomy (vertical incision in the sternum) or cardiopulmonary bypass (heart-lung machine). The ablation lines are created using a variety of energy sources including radiofrequency energy, cryoablation, and high intensity focused ultrasound.^[9]
Although Dr. Cox's 2004 definition specifically excludes an epicardial approach to eliminate atrial fibrillation (AF), he and others pursued this important goal, and the meaning of the term changed as successful epicardial procedures were developed. In 2002 Saltman performed a completely endoscopic surgical ablation of atrial fibrillation (AF) and subsequently published their results in 14 patients. ^[10]^[11]
These were performed epicardially, on the beating heart, without cardiopulmonary bypass or median sternotomy. Their method came to be known as the minimaze or microwave minimaze procedure, because microwave energy was used to make the lesions that had previously been performed by the surgeon's scalpel.
Shortly thereafter, Randall K. Wolf, MD, and others developed a procedure using radiofrequency energy rather than microwave, and different, slightly larger incisions. In 2005, he published his results in the first 27 patients. This procedure came to be known as the Wolf minimaze procedure.^[12]
Today, the terms “minimaze”, "mini-maze", and "mini maze" are still sometimes used to describe open-heart procedures requiring cardiopulmonary bypass and median sternotomy, but are more commonly they refer to minimally invasive, epicardial procedures not requiring cardiopulmonary bypasses, such as those developed by Saltman, Wolf, and others. These procedures are characterized by:

1. No median sternotomy incision; instead, an endoscope and/or “mini-thoracotomy” incisions between the ribs are used.
2. No cardiopulmonary bypass; instead, these procedures are performed on the normally beating heart.
3. Few or no actual [[incisions] into the heart itself. The "maze" lesions are made epicardially by using radiofrequency, microwave, or ultrasonic energy, or by cryosurgery.
4. The part of the left atrium in which most clots form (the “appendage”) is usually removed, in an effort to reduce the long-term likelihood of stroke.

Microwave Minimaze

Completely Endoscopic Microwave Ablation of Atrial Fibrillation on the Beating Heart Using Bilateral Thoracoscopy: ^[10]^[11]

The Microwave Minimaze requires three 5 mm to 1cm incisions on each side of the chest for the surgical tools and the endoscope. The pericardium is entered, and two sterile rubber tubes are threaded behind the heart, in the transverse and oblique sinuses.
These tubes are joined together, then used to guide the flexible microwave antenna energy source through the sinuses behind the heart, to position it for ablation. *Energy is delivered and the atrial tissue heated and destroyed in a series of steps as the microwave antenna is withdrawn behind the heart.
The lesions form a "box-like" pattern around all four pulmonary veins behind the heart. The left atrial appendage is usually removed.
A very thorough description of the procedure is available.

Wolf Minimaze

Video-Assisted Bilateral Epicardial Bipolar Radiofrequency Pulmonary Vein Isolation and Left Atrial Appendage Excision: ^[13]^[12]

The Wolf Minimaze requires one 5cm and two 1cm incisions on each side of the chest. These incisions allow the surgeon to maneuver the tools, view areas through an endoscope, and see the heart directly.
The right side of the left atrium is exposed first. A clamp-like tool is positioned on the left atrium near the right pulmonary veins, and the atrial tissue is heated between the jaws of the clamp, cauterizing the area. Then the clamp is removed.
The autonomic nerves (ganglionated plexi) that may cause atrial fibrillation and may be eliminate it as well.
Subsequently the left side of the chest is entered.
The ligament of Marshall (a vestigial structure with marked autonomic activity) is removed. The clamp is subsequently positioned on the left atrium near the left pulmonary veins for ablation.
Direct testing to demonstrate complete electrical isolation of the pulmonary veins, and that the ganglionated plexi is no longer active, may be performed.

High Intensity Focused Ultrasound (HIFU) Minimaze

Surgical Ablation of Atrial Fibrillation with Off-Pump, Epicardial, High-Intensity Focused Ultrasound: ^[14]

Although the HIFU minimaze is performed epicardially, on the normally beating heart, it is also usually performed in conjunction with other cardiac surgery, and so would not be minimally invasive in those cases. An ultrasonic device is positioned epicardially, on the left atrium, around the pulmonary veins, and intense acoustic energy is directed at the atrium to destroy tissue in the appropriate regions near the pulmonary veins.

Mechanism of Elimination of Atrial Fibrillation

The mechanism by which atrial fibrillation is eliminated by curative procedures such as the maze, minimaze, or catheter ablation is controversial. ^[13]
All successful methods destroy tissue in the areas of the left atrium near the junction of the pulmonary veins, hence these regions are thought to be important.
A concept gaining support is that paroxysmal atrial fibrillation is mediated in part by the autonomic nervous system and that the intrinsic cardiac nervous system, which is located in these regions, plays an important role.^[13]^[15]
Targeting these autonomic sites improves the likelihood of successful elimination of atrial fibrillation by catheter ablation.^[16]^[17]

Patient Selection

The Minimaze procedures are alternatives to catheter ablation of atrial fibrillation, and the patient selection criteria are similar.^[2]
Patients are considered for Minimaze procedures if they have moderate or severe symptoms and have failed medical therapy; on the other hand asymptomatic patients are generally not considered.^[2]
Those most likely to have a good outcome have paroxysmal (intermittent) atrial fibrillation, and have a heart that is relatively normal.
Those with severely enlarged atria, marked cardiomyopathy, or severely leaking heart valves are less likely to have a successful result hence these procedures are generally not recommended for such patients.
Previous cardiac surgery provides technical challenges due to scarring on the outside of the heart, but does not always preclude Minimaze surgery.

Surgical Results

Long-term success of the Minimaze procedures awaits a consensus. Attaining a consensus is hindered by several problems; perhaps the most important of these is incomplete or inconsistent post-procedure follow-up to determine if atrial fibrillation has recurred.^[6]
It has been clearly demonstrated that longer or more intensive follow-up identifies much more recurrent atrial fibrillation, hence a procedure with more careful follow-up will appear to be less successful.^[18]
In addition, procedures continue to evolve rapidly, so long follow-up data do not accurately reflect current procedural methods. For more recent Minimaze procedures, only relatively small and preliminary reports are available.
A new metric ("Single Procedure Risk Adjusted Success") has been proposed in an attempt to control for some of these inconsistencies, but it has not been widely accepted. With those caveats in mind, it can be said that reported short-term success rates range from 67% to 91%.^[11]^[12]^[14]
Currently the limitation of ablation procedure deployed through a minimal access incision or port, constraints on the location and number of ablation lesions that can be performed.

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary (DO NOT EDIT)^[19]

Rhythm Control

Surgery Maze Procedures

Class IIa
"1. An AF surgical ablation procedure is reasonable for selected patients with AF undergoing cardiac surgery for other indications. (Level of Evidence: C)"

Class IIb
"1. A stand-alone AF surgical ablation procedure may be reasonable for selected patients with highly symptomatic AF not well managed with other approaches. (Level of Evidence: B)"

Sources

AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary^[19]

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation ^[1]
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation ^[20]
ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter ^[21]
A more complete current listing of minimaze references can be obtained by this search at the Cardiothoracic Surgery Network

External links

Surgical Treatments for Atrial Fibrillation
Surgical Treatment of Supraventricular Tachyarrhythmias in Cardiac Surgery in the Adult
Cardiologic Interventional Therapy for Atrial and Ventricular Arrhythmias in Cardiac Surgery in the Adult

References

↑ ^1.0 ^1.1 Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (7): e257–354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781. Retrieved 2013-01-07. Unknown parameter |month= ignored (help)
↑ ^2.0 ^2.1 ^2.2 ^2.3 ^2.4 ^2.5 ^2.6 ^2.7 ^2.8 ^2.9 Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee (2021). "Atrial fibrillation: diagnosis and management-summary of NICE guidance". BMJ. 373: n1150. doi:10.1136/bmj.n1150. PMID 34020968 Check |pmid= value (help).
↑ ^3.0 ^3.1 ^3.2 Sarabanda, AV.; Bunch, TJ.; Johnson, SB.; Mahapatra, S.; Milton, MA.; Leite, LR.; Bruce, GK.; Packer, DL. (2005). "Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system". J Am Coll Cardiol. 46 (10): 1902–12. doi:10.1016/j.jacc.2005.07.046. PMID 16286179. Unknown parameter |month= ignored (help)
↑ ^4.0 ^4.1 Cox J, Schuessler R, D'Agostino H, Stone C, Chang B, Cain M, Corr P, Boineau J (1991). "The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure". J Thorac Cardiovasc Surg. 101 (4): 569–83. PMID 2008095.
↑ ^5.0 ^5.1 Cox JL, Churyla A, Malaisrie SC, Kruse J, Pham DT, Kislitsina ON; et al. (2018). "When Is a Maze Procedure a Maze Procedure?". Can J Cardiol. 34 (11): 1482–1491. doi:10.1016/j.cjca.2018.05.008. PMID 30121148.
↑ ^6.0 ^6.1 Prasad S, Maniar H, Camillo C, Schuessler R, Boineau J, Sundt T, Cox J, Damiano R (2003). "The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures". J Thorac Cardiovasc Surg. 126 (6): 1822–8. PMID 14688693.
↑ Szalay Z, Skwara W, Pitschner H, Faude I, Klövekorn W, Bauer E (1999). "Midterm results after the mini-maze procedure". Eur J Cardiothorac Surg. 16 (3): 306–11. PMID 10554849.
↑ Cox J (2004). "The role of surgical intervention in the management of atrial fibrillation". Tex Heart Inst J. 31 (3): 257–65. PMID 15562846.
↑ ^9.0 ^9.1 Khargi, K.; Hutten, BA.; Lemke, B.; Deneke, T. (2005). "Surgical treatment of atrial fibrillation; a systematic review". Eur J Cardiothorac Surg. 27 (2): 258–65. doi:10.1016/j.ejcts.2004.11.003. PMID 15691679. Unknown parameter |month= ignored (help)
↑ ^10.0 ^10.1 Saltman A, Rosenthal L, Francalancia N, Lahey S (2003). "A completely endoscopic approach to microwave ablation for atrial fibrillation". Heart Surg Forum. 6 (3): E38–41. PMID 12821436.
↑ ^11.0 ^11.1 ^11.2 Salenger R, Lahey S, Saltman A (2004). "The completely endoscopic treatment of atrial fibrillation: report on the first 14 patients with early results". Heart Surg Forum. 7 (6): E555–8. PMID 15769685.
↑ ^12.0 ^12.1 ^12.2 Wolf R, Schneeberger E, Osterday R, Miller D, Merrill W, Flege J, Gillinov A (2005). "Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation". J Thorac Cardiovasc Surg. 130 (3): 797–802. PMID 16153931.
↑ ^13.0 ^13.1 ^13.2 Coumel P. "Paroxysmal atrial fibrillation: a disorder of autonomic tone?". Eur Heart J. 15 Suppl A: 9–16. PMID 8070496.
↑ ^14.0 ^14.1 Ninet J, Roques X, Seitelberger R, Deville C, Pomar J, Robin J, Jegaden O, Wellens F, Wolner E, Vedrinne C, Gottardi R, Orrit J, Billes M, Hoffmann D, Cox J, Champsaur G (2005). "Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial". J Thorac Cardiovasc Surg. 130 (3): 803–9. PMID 16153932.
↑ Scherlag B, Po S (2006). "The intrinsic cardiac nervous system and atrial fibrillation". Curr Opin Cardiol. 21 (1): 51–4. PMID 16355030.
↑ Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O (2004). "Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation". Circulation. 109 (3): 327–34. PMID 14707026.
↑ Scherlag B, Nakagawa H, Jackman W, Yamanashi W, Patterson E, Po S, Lazzara R (2005). "Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation". J Interv Card Electrophysiol. 13 Suppl 1: 37–42. PMID 16133854.
↑ Israel C, Grönefeld G, Ehrlich J, Li Y, Hohnloser S (2004). "Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care". J Am Coll Cardiol. 43 (1): 47–52. PMID 14715182.
↑ ^19.0 ^19.1 January, Craig T.; Wann, L. Samuel; Alpert, Joseph S.; Calkins, Hugh; Cleveland, Joseph C.; Cigarroa, Joaquin E.; Conti, Jamie B.; Ellinor, Patrick T.; Ezekowitz, Michael D.; Field, Michael E.; Murray, Katherine T.; Sacco, Ralph L.; Stevenson, William G.; Tchou, Patrick J.; Tracy, Cynthia M.; Yancy, Clyde W. (2014). "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary". Journal of the American College of Cardiology. doi:10.1016/j.jacc.2014.03.021. ISSN 0735-1097.
↑ Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123 (10):e269-367. DOI:10.1161/CIR.0b013e318214876d PMID: 21382897
↑ Estes NA, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS et al. (2008) ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation 117 (8):1101-20. DOI:10.1161/CIRCULATIONAHA.107.187192 PMID: 18283199

Template:WikiDoc Sources CME Category::Cardiology

[pmid16908781-1] 1.0 ^1.1 Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (7): e257–354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781. Retrieved 2013-01-07. Unknown parameter |month= ignored (help)

[pmid34020968-2] 2.0 ^2.1 ^2.2 ^2.3 ^2.4 ^2.5 ^2.6 ^2.7 ^2.8 ^2.9 Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee (2021). "Atrial fibrillation: diagnosis and management-summary of NICE guidance". BMJ. 373: n1150. doi:10.1136/bmj.n1150. PMID 34020968 Check |pmid= value (help).

[Sarabanda-2005-3] 3.0 ^3.1 ^3.2 Sarabanda, AV.; Bunch, TJ.; Johnson, SB.; Mahapatra, S.; Milton, MA.; Leite, LR.; Bruce, GK.; Packer, DL. (2005). "Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system". J Am Coll Cardiol. 46 (10): 1902–12. doi:10.1016/j.jacc.2005.07.046. PMID 16286179. Unknown parameter |month= ignored (help)

[Cox_1991-4] 4.0 ^4.1 Cox J, Schuessler R, D'Agostino H, Stone C, Chang B, Cain M, Corr P, Boineau J (1991). "The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure". J Thorac Cardiovasc Surg. 101 (4): 569–83. PMID 2008095.

[pmid30121148-5] 5.0 ^5.1 Cox JL, Churyla A, Malaisrie SC, Kruse J, Pham DT, Kislitsina ON; et al. (2018). "When Is a Maze Procedure a Maze Procedure?". Can J Cardiol. 34 (11): 1482–1491. doi:10.1016/j.cjca.2018.05.008. PMID 30121148.

[Prasad_2003-6] 6.0 ^6.1 Prasad S, Maniar H, Camillo C, Schuessler R, Boineau J, Sundt T, Cox J, Damiano R (2003). "The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures". J Thorac Cardiovasc Surg. 126 (6): 1822–8. PMID 14688693.

[Szalaya_1999-7] Szalay Z, Skwara W, Pitschner H, Faude I, Klövekorn W, Bauer E (1999). "Midterm results after the mini-maze procedure". Eur J Cardiothorac Surg. 16 (3): 306–11. PMID 10554849.

[Cox_2004-8] Cox J (2004). "The role of surgical intervention in the management of atrial fibrillation". Tex Heart Inst J. 31 (3): 257–65. PMID 15562846.

[Khargi-2005-9] 9.0 ^9.1 Khargi, K.; Hutten, BA.; Lemke, B.; Deneke, T. (2005). "Surgical treatment of atrial fibrillation; a systematic review". Eur J Cardiothorac Surg. 27 (2): 258–65. doi:10.1016/j.ejcts.2004.11.003. PMID 15691679. Unknown parameter |month= ignored (help)

[Saltman_2003-10] 10.0 ^10.1 Saltman A, Rosenthal L, Francalancia N, Lahey S (2003). "A completely endoscopic approach to microwave ablation for atrial fibrillation". Heart Surg Forum. 6 (3): E38–41. PMID 12821436.

[Salenger_2004-11] 11.0 ^11.1 ^11.2 Salenger R, Lahey S, Saltman A (2004). "The completely endoscopic treatment of atrial fibrillation: report on the first 14 patients with early results". Heart Surg Forum. 7 (6): E555–8. PMID 15769685.

[Wolf_2005-12] 12.0 ^12.1 ^12.2 Wolf R, Schneeberger E, Osterday R, Miller D, Merrill W, Flege J, Gillinov A (2005). "Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation". J Thorac Cardiovasc Surg. 130 (3): 797–802. PMID 16153931.

[Coumel_1994-13] 13.0 ^13.1 ^13.2 Coumel P. "Paroxysmal atrial fibrillation: a disorder of autonomic tone?". Eur Heart J. 15 Suppl A: 9–16. PMID 8070496.

[Ninet_2005-14] 14.0 ^14.1 Ninet J, Roques X, Seitelberger R, Deville C, Pomar J, Robin J, Jegaden O, Wellens F, Wolner E, Vedrinne C, Gottardi R, Orrit J, Billes M, Hoffmann D, Cox J, Champsaur G (2005). "Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial". J Thorac Cardiovasc Surg. 130 (3): 803–9. PMID 16153932.

[Scherlag_2006-15] Scherlag B, Po S (2006). "The intrinsic cardiac nervous system and atrial fibrillation". Curr Opin Cardiol. 21 (1): 51–4. PMID 16355030.

[Pappone_2004-16] Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O (2004). "Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation". Circulation. 109 (3): 327–34. PMID 14707026.

[Scherlag_2005-17] Scherlag B, Nakagawa H, Jackman W, Yamanashi W, Patterson E, Po S, Lazzara R (2005). "Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation". J Interv Card Electrophysiol. 13 Suppl 1: 37–42. PMID 16133854.

[Israel_2004-18] Israel C, Grönefeld G, Ehrlich J, Li Y, Hohnloser S (2004). "Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care". J Am Coll Cardiol. 43 (1): 47–52. PMID 14715182.

[JanuaryWann2014-19] 19.0 ^19.1 January, Craig T.; Wann, L. Samuel; Alpert, Joseph S.; Calkins, Hugh; Cleveland, Joseph C.; Cigarroa, Joaquin E.; Conti, Jamie B.; Ellinor, Patrick T.; Ezekowitz, Michael D.; Field, Michael E.; Murray, Katherine T.; Sacco, Ralph L.; Stevenson, William G.; Tchou, Patrick J.; Tracy, Cynthia M.; Yancy, Clyde W. (2014). "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary". Journal of the American College of Cardiology. doi:10.1016/j.jacc.2014.03.021. ISSN 0735-1097.

[pmid21382897-20] Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123 (10):e269-367. DOI:10.1161/CIR.0b013e318214876d PMID: 21382897

[pmid18283199-21] Estes NA, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS et al. (2008) ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation 117 (8):1101-20. DOI:10.1161/CIRCULATIONAHA.107.187192 PMID: 18283199

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

@@ Line 5: / Line 5: @@
 |}
 {{Atrial fibrillation}}
-{{CMG}}; {{AE}} {{CZ}} {{VR}}
+{{CMG}}; {{AE}} {{CZ}} {{Anahita}} {{VR}}
 {{SK}} Cox-Maze, Cox Maze, Maze, Minimaze, Mini Maze, Mini-Maze, Cox maze procedure, Maze procedure, Minimaze procedure
 ==Overview==
+The Maze procedure is a [[surgery|surgical]] [[treatment]] option for some [[patients]] with [[atrial fibrillation]]. In this procedure, a series of [[incisions]] in a cross-like pattern is made on the [[atrium|atria]], which blocks the abnormal [[atrium|atria]] circuits, hence eliminating the [[atrial fibrillation]]. A number of improvements have been made to this [[surgery|surgical procedure]] since it was first invented. Recently, various methods of minimally invasive maze procedures have been developed; these procedures are collectively named minimaze, mini versions of the original maze [[surgery]].
-A surgical option for some patients with atrial fibrillation is the maze procedure.  In this procedure, a series of incisions in a cross like pattern are made on the [[atria]], which blocks the abnormal atrial circuits, hence eliminating the atrial fibrillation.  A number of improvements have been made to this surgical procedure since it was first invented.  Recently, various methods of minimally invasive maze procedures have been developed; these procedures are collectively named as minimaze, mini versions of the original maze surgery.
 ==Indications for Catheter and Surgical Ablation==
-Ablation of atrial fibrillation is recommended when the primary indication is the presence of symptomatic AF, which is refractory or intolerant to at least one class I or III [[antiarrhythmic medication]].  The indications are stratified as class I, class IIa, class IIb, and class III indications.<ref name="pmid16908781">{{cite journal |author=Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL |title=ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society |journal=[[Circulation]] |volume=114 |issue=7 |pages=e257–354 |year=2006 |month=August |pmid=16908781 |doi=10.1161/CIRCULATIONAHA.106.177292 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=16908781 |accessdate=2013-01-07}}</ref>
+*[[Ablation]] of [[atrial fibrillation]] is recommended in the presence of [[symptom|symptomatic]] [[atrial fibrillation]], which is refractory or intolerant to at least one class I or III [[antiarrhythmic medication]]. The indications are stratified as class I, class IIa, class IIb, and class III.<ref name="pmid16908781">{{cite journal |author=Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL |title=ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society |journal=[[Circulation]] |volume=114 |issue=7 |pages=e257–354 |year=2006 |month=August |pmid=16908781 |doi=10.1161/CIRCULATIONAHA.106.177292 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=16908781 |accessdate=2013-01-07}}</ref>
 ===Class I Indications===
-In symptomatic paroxysmal AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, catheter ablation is recommended.
+In [[symptom|symptomatic]] paroxysmal [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], [[catheter]] [[ablation]] is recommended.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
 ===Class IIa Indications===
-*In symptomatic persistent AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, catheter ablation is reasonable.
+*In [[symptom|symptomatic]] persistent [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], [[catheter]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-*In symptomatic paroxysmal AF patients, prior to initiation of antiarrhythmic drug therapy with either class I or III antiarrhythmic agent, catheter ablation is reasonable.
+*In [[symptom|symptomatic]] paroxysmal [[atrial fibrillation]] [[patients]], prior to initiation of [[Antiarrhythmic agent|antiarrhythmic drug]] [[therapy]] with either class I or III [[antiarrhythmic agent]], [[catheter]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-*In patients who are undergoing surgery for other indications with symptomatic paroxysmal AF, refractory or intolerant to at least one class I or III antiarrhythmic medication, surgical ablation is reasonable.
+*In [[patients]] who are undergoing [[surgery]] for other indications with [[symptom|symptomatic]] paroxysmal [[atrial fibrillation]], refractory or intolerant to at least one [[antiarrhythmic agent|class I or III antiarrhythmic medication]], [[surgery|surgical]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-*In patients who are undergoing surgery for other indications with symptomatic persistent AF, refractory or intolerant to at least one class I or III antiarrhythmic medication, surgical ablation is reasonable.
+*In [[patients]] who are undergoing [[surgery]] for other indications with [[sympto|symptomatic]] persistent [[atrial fibrillation]], refractory or intolerant to at least one class I or III [[Antiarrhythmic agent|antiarrhythmic drug]], [[surgery|surgical]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-*In patients who are undergoing surgery for other indications with symptomatic longstanding persistent AF, refractory or intolerant to at least one class I or III antiarrhythmic medication, surgical ablation is reasonable.
+*In [[patients]] who are undergoing [[surgery]] for other indications with [[symptom|symptomatic]] longstanding persistent [[atrial fibrillation]], refractory or intolerant to at least one class I or III [[Antiarrhythmic agent|antiarrhythmic drug]], [[surgery|surgical]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-*In patients who are undergoing surgery for other indications with symptomatic paroxysmal AF prior to initiation of antiarrhythmic drug therapy with either class I or III antiarrhythmic agent, surgical ablation is reasonable.
+*In [[patients]] who are undergoing [[surgery]] for other indications with [[symptom|symptomatic]] paroxysmal [[atrial fibrillation]] prior to initiation of [[Antiarrhythmic agent|antiarrhythmic drug]] [[therapy]] with either class I or III [[Antiarrhythmic agent|antiarrhythmic drug]], [[surgery|surgical]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-*In patients who are undergoing surgery for other indications with symptomatic persistent AF prior to initiation of antiarrhythmic drug therapy with either class I or III antiarrhythmic agent, surgical ablation is reasonable.
+*In [[patients]] who are undergoing [[surgery]] for other indications with [[symptom|symptomatic]] persistent [[atrial fibrillation]] prior to initiation of [[antiarrhythmic drug]] [[therapy]] with either class I or III [[antiarrhythmic agent]], [[surgery|surgical]] [[ablation]] is reasonable.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
 ===Class IIb Indications===
-*In symptomatic longstanding persistent AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, catheter ablation may be considered.
+*In [[symptom|symptomatic]] longstanding persistent [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one class I or III [[antiarrhythmic agent]], [[catheter]] [[ablation]] may be considered.<ref name="Sarabanda-2005">{{Cite journal  | last1 = Sarabanda | first1 = AV. | last2 = Bunch | first2 = TJ. | last3 = Johnson | first3 = SB. | last4 = Mahapatra | first4 = S. | last5 = Milton | first5 = MA. | last6 = Leite | first6 = LR. | last7 = Bruce | first7 = GK. | last8 = Packer | first8 = DL. | title = Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. | journal = J Am Coll Cardiol | volume = 46 | issue = 10 | pages = 1902-12 | month = Nov | year = 2005 | doi = 10.1016/j.jacc.2005.07.046 | PMID = 16286179 }}</ref>
-*In patients with symptomatic persistent AF prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic medication, catheter ablation may be considered.
+*In [[patients]] with [[symptom|symptomatic]] persistent [[atrial fibrillation]] prior to initiation of [[Antiarrhythmic agent|antiarrhythmic drug]] [[therapy]] with a [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], [[catheter]] [[ablation]] may be considered.
-*In patients with symptomatic longstanding persistent AF prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic medication, catheter ablation may be considered.
+*In [[patients]] with [[symptom|symptomatic]] longstanding persistent [[atrial fibrillation]] prior to initiation of [[Antiarrhythmic agent|antiarrhythmic drug]] [[therapy]] with a [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], [[catheter]] [[ablation]] may be considered.<ref name="Sarabanda-2005">{{Cite journal  | last1 = Sarabanda | first1 = AV. | last2 = Bunch | first2 = TJ. | last3 = Johnson | first3 = SB. | last4 = Mahapatra | first4 = S. | last5 = Milton | first5 = MA. | last6 = Leite | first6 = LR. | last7 = Bruce | first7 = GK. | last8 = Packer | first8 = DL. | title = Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. | journal = J Am Coll Cardiol | volume = 46 | issue = 10 | pages = 1902-12 | month = Nov | year = 2005 | doi = 10.1016/j.jacc.2005.07.046 | PMID = 16286179 }}</ref>
-*In patients who are undergoing surgery for other indications with symptomatic longstanding persistent AF prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic agent, surgical ablation may be considered.
+*In [[patients]] who are undergoing [[surgery]] for other indications with [[symptom|symptomatic]] longstanding persistent [[atrial fibrillation]] prior to initiation of [[Antiarrhythmic agent|antiarrhythmic drug]] [[therapy]] with a [[[Antiarrhythmic agent|class I or III antiarrhythmic agent]], [[surgery|surgical]] [[ablation]] may be considered.
-*In symptomatic paroxysmal AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have not failed catheter ablation but prefer a surgical approach.
+*In [[symptom|symptomatic]] paroxysmal [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[[[Antiarrhythmic agent|class I or III antiarrhythmic medication]], stand alone [[surgery|surgical]] [[ablation]] may be considered if they have not failed [[catheter]] [[ablation]] but prefer a [[suregry|surgical]] approach.
-*In symptomatic paroxysmal AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have failed one or more attempts at catheter ablation.
+*In [[symptom|symptomatic]] paroxysmal [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], stand alone [[surgery|surgical]] [[ablation]] may be considered if they have failed one or more attempts at [[catheter]] [[ablation]].
-*In symptomatic persistent AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have not failed catheter ablation but prefer a surgical approach.
+*In [[symptom|symptomatic]] persistent [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], stand alone [[surgery|surgical]] [[ablation]] may be considered if they have not failed [[catheter]] [[ablation]] but prefer a [[surgery|surgical approach]].
-*In symptomatic persistent AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have failed one or more attempts at catheter ablation.
+*In [[symptom|symptomatic]] persistent [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], stand alone [[surgery|surgical]] [[ablation]] may be considered if they have failed one or more attempts at [[catheter]] [[ablation]].
-*In symptomatic longstanding persistent AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have not failed catheter ablation but prefer a surgical approach.
+*In [[symptom|symptomatic]] longstanding persistent [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], stand alone [[surgery|surgical]] [[ablation]] may be considered if they have not failed [[catheter]] [[ablation]] but prefer a [[surgery|surgical]] approach.
-*In symptomatic longstanding persistent AF patients who are either refractory or intolerant to at least one class I or III antiarrhythmic medication, stand alone surgical ablation may be considered if they have failed one or more attempts at catheter ablation.
+*In [[symptom|symptomatic]] longstanding persistent [[atrial fibrillation]] [[patients]] who are either refractory or intolerant to at least one [[Antiarrhythmic agent|class I or III antiarrhythmic medication]], stand alone [[surgery|surgical]] [[ablation]] may be considered if they have failed one or more attempts at [[catheter]] [[ablation]].
 ===Class III Indications===
-In symptomatic paroxysmal or persistent or longstanding persistent AF patients, prior to initiation of antiarrhythmic drug therapy with a class I or III antiarrhythmic agent, stand alone surgical ablation is not recommended.
+In [[symptom|symptomatic]] paroxysmal or persistent or longstanding persistent [[atrial fibrillation]] [[patients]], prior to initiation of [[Antiarrhythmic agent|antiarrhythmic drug]] [[therapy]] with a [[Antiarrhythmic agent|class I or III antiarrhythmic agent]], stand alone [[surgery|surgical]] [[ablation]] is not recommended.<ref name="Sarabanda-2005">{{Cite journal  | last1 = Sarabanda | first1 = AV. | last2 = Bunch | first2 = TJ. | last3 = Johnson | first3 = SB. | last4 = Mahapatra | first4 = S. | last5 = Milton | first5 = MA. | last6 = Leite | first6 = LR. | last7 = Bruce | first7 = GK. | last8 = Packer | first8 = DL. | title = Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. | journal = J Am Coll Cardiol | volume = 46 | issue = 10 | pages = 1902-12 | month = Nov | year = 2005 | doi = 10.1016/j.jacc.2005.07.046 | PMID = 16286179 }}</ref>
 ==Surgical Ablation==
@@ Line 52: / Line 52: @@
 ===Cox Maze Procedure===
-James Cox, MD, and associates developed the "Maze" or "Cox Maze" procedure, an "open-heart" [[cardiac surgery]] procedure intended to eliminate [[atrial fibrillation]], and performed the first one in 1987.<ref name="Cox 1991">{{cite journal | author = Cox J, Schuessler R, D'Agostino H, Stone C, Chang B, Cain M, Corr P, Boineau J | title = The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. | journal = J Thorac Cardiovasc Surg | volume = 101 | issue = 4 | pages = 569-83 | year = 1991 | id = PMID 2008095}}</ref>  Maze refers to the series of incisions arranged in a maze-like pattern in the [[atria]].  The intention was to eliminate [[AF]] by using incisional scars to block abnormal electrical circuits (atrial macroreentry) that AF requires.  This required an extensive series of [[endocardial]] (from the inside of the heart) incisions through both atria, a [[median sternotomy]] (vertical incision through the breastbone) and [[cardiopulmonary bypass]] ([[heart-lung machine]]; [[extracorporeal circulation]]).  A series of improvements were made, culminating in 1992 in the Cox Maze III procedure, which is now considered to be the "gold standard” for effective surgical cure of AF.  It was quite successful in eliminating AF, but had drawbacks as well.<ref name="Prasad 2003">{{cite journal | author = Prasad S, Maniar H, Camillo C, Schuessler R, Boineau J, Sundt T, Cox J, Damiano R | title = The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. | journal = J Thorac Cardiovasc Surg | volume = 126 | issue = 6 | pages = 1822-8 | year = 2003 | id = PMID 14688693}}</ref> The Cox Maze III is sometimes referred to as the “Traditional Maze”, the “cut and sew Maze”, or simply the "Maze".
+*James Cox, MD, and associates developed the "Maze" or "Cox Maze" procedure, an "open-heart" [[cardiac surgery]] procedure intended to eliminate [[atrial fibrillation]], and performed the first one in 1987.<ref name="Cox 1991">{{cite journal | author = Cox J, Schuessler R, D'Agostino H, Stone C, Chang B, Cain M, Corr P, Boineau J | title = The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. | journal = J Thorac Cardiovasc Surg | volume = 101 | issue = 4 | pages = 569-83 | year = 1991 | id = PMID 2008095}}</ref>
+*Maze refers to the series of incisions arranged in a maze-like pattern in the [[atrium|atria]].<ref name="pmid30121148">{{cite journal| author=Cox JL, Churyla A, Malaisrie SC, Kruse J, Pham DT, Kislitsina ON | display-authors=etal| title=When Is a Maze Procedure a Maze Procedure? | journal=Can J Cardiol | year= 2018 | volume= 34 | issue= 11 | pages= 1482-1491 | pmid=30121148 | doi=10.1016/j.cjca.2018.05.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30121148  }} </ref>
-Efforts have since been made to equal the success of the Cox Maze III while reducing surgical complexity and likelihood of complications.  During the late 1990s, operations similar to the Cox Maze, but with fewer [[atrial]] incisions, led to the use of the terms "Minimaze", "Mini Maze" and “Mini-Maze”,<ref name="Szalaya 1999">{{cite journal | author = Szalay Z, Skwara W, Pitschner H, Faude I, Klövekorn W, Bauer E | title = Midterm results after the mini-maze procedure. | journal = Eur J Cardiothorac Surg | volume = 16 | issue = 3 | pages = 306-11 | year = 1999 | id = PMID 10554849}}</ref> although these were still major operations.
+*The intention was to eliminate [[atrial fibrillation]] by using incisional [[scars]] to block abnormal electrical circuits ([[atrium|atrial]] macroreentry) that [[atrial fibrillation]] requires.<ref name="pmid30121148">{{cite journal| author=Cox JL, Churyla A, Malaisrie SC, Kruse J, Pham DT, Kislitsina ON | display-authors=etal| title=When Is a Maze Procedure a Maze Procedure? | journal=Can J Cardiol | year= 2018 | volume= 34 | issue= 11 | pages= 1482-1491 | pmid=30121148 | doi=10.1016/j.cjca.2018.05.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30121148  }} </ref>
+*This required an extensive series of [[endocardial]] (from the inside of the [[heart]]) incisions through both [[atrium|atria]], a [[median sternotomy]] (vertical [[incision]] through the [[sternum]]) and [[cardiopulmonary bypass]] ([[heart-lung machine]]; [[extracorporeal circulation]]).
-A primary goal has been to perform a curative, "Maze-like" procedure, epicardially (from the outside of the heart), so that it could be performed on a normally beating heart, without cardiopulmonary bypass.  Until recently this was not thought possible; as recently as 2004, Dr. Cox defined the Mini-Maze as requiring an [[endocardial]] approach:
+*A series of improvements were made, culminating in 1992 in the Cox Maze III procedure, which is now considered to be the "gold standard” for effective [[surgery|surgical cure]] of [[atrial fibrillation]].<ref name="Cox 1991">{{cite journal | author = Cox J, Schuessler R, D'Agostino H, Stone C, Chang B, Cain M, Corr P, Boineau J | title = The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. | journal = J Thorac Cardiovasc Surg | volume = 101 | issue = 4 | pages = 569-83 | year = 1991 | id = PMID 2008095}}</ref>
+*It was quite successful in eliminating [[atrial fibrillation]], but had drawbacks as well.<ref name="Prasad 2003">{{cite journal | author = Prasad S, Maniar H, Camillo C, Schuessler R, Boineau J, Sundt T, Cox J, Damiano R | title = The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. | journal = J Thorac Cardiovasc Surg | volume = 126 | issue = 6 | pages = 1822-8 | year = 2003 | id = PMID 14688693}}</ref>
+*The Cox Maze III is sometimes referred to as the “Traditional Maze”, the “cut and sew Maze”, or simply the "Maze".
+*Efforts have since been made to equal the success of the Cox Maze III while reducing [[surgery|surgical]] complexity and the likelihood of [[Complication (medicine)|complications]]. During the late 1990s, operations similar to the Cox-Maze, but with fewer [[atrial]] incisions, led to the use of the terms "Minimaze", "Mini Maze" and “Mini-Maze”, although these were still major [[surgery|operations]].<ref name="Szalaya 1999">{{cite journal | author = Szalay Z, Skwara W, Pitschner H, Faude I, Klövekorn W, Bauer E | title = Midterm results after the mini-maze procedure. | journal = Eur J Cardiothorac Surg | volume = 16 | issue = 3 | pages = 306-11 | year = 1999 | id = PMID 10554849}}</ref>
+*A primary goal has been to perform a curative, "Maze-like" procedure, epicardially (from the outside of the [[heart]]), so that it could be performed on a normally beating [[heart]], without [[cardiopulmonary bypass]]. Until recently this was not thought possible; as recently as 2004, Dr. Cox defined the Mini-Maze as requiring an [[endocardial]] approach:
-<blockquote>“In summary, it would appear that placing the following lesions can cure most patients with [[atrial fibrillation]] of either type: [[pulmonary vein]] encircling incision, left atrial isthmus lesion with its attendant coronary sinus lesion, and the right [[atrial]] isthmus lesion.  We call this pattern of [[atrial]] lesions the “Mini-Maze Procedure” ... None of the present energy sources—including cryotherapy, unipolar radiofrequency, irrigated radiofrequency, bipolar radiofrequency, microwave, and laser energy—are capable of creating the left atrial isthmus lesion from the epicardial surface, because of the necessity of penetrating through the circumflex [[coronary artery]] to reach the left atrial wall near the posterior [[mitral]] annulus.  Therefore, the Mini-Maze Procedure cannot be performed epicardially by means of any presently available energy source.”<ref name="Cox 2004">{{cite journal | author = Cox J | title = The role of surgical intervention in the management of atrial fibrillation. | journal = Tex Heart Inst J | volume = 31 | issue = 3 | pages = 257-65 | year = 2004 | id = PMID 15562846}}</ref></blockquote>
+<blockquote>“In summary, it would appear that placing the following [[lesions]] can cure most [[patients]] with [[atrial fibrillation]] of either type: [[pulmonary vein]] encircling [[incision]], [[Left atrium|left atrial isthmus]] [[lesion]] with its attendant [[coronary sinus]] lesion, and the right [[atrial]] [[isthmus]] [[lesion]]. We call this pattern of [[atrial]] lesions the “Mini-Maze Procedure” … None of the present energy sources—including [[cryotherapy]], unipolar radiofrequency, irrigated radiofrequency, bipolar radiofrequency, microwave, and laser energy—are capable of creating the [[Left atrium|left atrial isthmus]] lesion from the [[epicardial]] surface, because of the necessity of penetrating through the circumflex [[coronary artery]] to reach the [[Left atrium|left atrial]] wall near the posterior [[mitral]] annulus. Therefore, the Mini-Maze procedure cannot be performed [[epicardial|epicardially]] by means of any presently available energy source.”<ref name="Cox 2004">{{cite journal | author = Cox J | title = The role of surgical intervention in the management of atrial fibrillation. | journal = Tex Heart Inst J | volume = 31 | issue = 3 | pages = 257-65 | year = 2004 | id = PMID 15562846}}</ref></blockquote>
 ===Minimally Invasive Epicardial Surgical Procedures===
-Despite its efficacy, the Cox-Maze procedure did not gain widespread application due to its complexity, technical difficulty, and risks.  In an attempt to simplify the operation and make it more accessible, the incisions of the traditional cut-and-sew Cox-Maze procedure has been replaced with linear lines of ablation.  They are called as minimaze surgeries.  These procedures are less invasive than the Cox-Maze procedure and do not require a [[median sternotomy]] (vertical incision in the breastbone) or [[cardiopulmonary bypass]] ([[heart-lung machine]]).  The ablation lines are created using a variety of energy sources including [[radiofrequency]] energy, [[cryoablation]], and [[high intensity focused ultrasound]].<ref name="Khargi-2005">{{Cite journal  | last1 = Khargi | first1 = K. | last2 = Hutten | first2 = BA. | last3 = Lemke | first3 = B. | last4 = Deneke | first4 = T. | title = Surgical treatment of atrial fibrillation; a systematic review. | journal = Eur J Cardiothorac Surg | volume = 27 | issue = 2 | pages = 258-65 | month = Feb | year = 2005 | doi = 10.1016/j.ejcts.2004.11.003 | PMID = 15691679 }}</ref>  Although Dr. Cox's 2004 definition specifically excludes an epicardial approach to eliminate [[AF]], he and others pursued this important goal, and the meaning of the term changed as successful epicardial procedures were developed.  In 2002 Saltman performed a completely [[endoscopic]] surgical [[ablation]] of [[AF]]<ref name="Saltman 2003"/> and subsequently published their results in 14 patients.<ref name="Salenger 2004">{{cite journal | author = Salenger R, Lahey S, Saltman A | title = The completely endoscopic treatment of atrial fibrillation: report on the first 14 patients with early results. | journal = Heart Surg Forum | volume = 7 | issue = 6 | pages = E555-8 | year = 2004 | id = PMID 15769685}}</ref>   These were performed epicardially, on the beating heart, without cardiopulmonary bypass or median sternotomy.  Their method came to be known as the minimaze or microwave minimaze procedure, because microwave energy was used to make the lesions that had previously been performed by the surgeon's scalpel.
+*Despite its efficacy, the Cox-Maze procedure did not gain widespread application due to its complexity, technical difficulty, and risks. In an attempt to simplify the [[surgery|operation]] and make it more accessible, the [[incisions]] of the traditional cut-and-sew Cox-Maze procedure has been replaced with linear lines of [[ablation]]. They are called minimaze [[surgery|surgeries]].<ref name="Khargi-2005">{{Cite journal  | last1 = Khargi | first1 = K. | last2 = Hutten | first2 = BA. | last3 = Lemke | first3 = B. | last4 = Deneke | first4 = T. | title = Surgical treatment of atrial fibrillation; a systematic review. | journal = Eur J Cardiothorac Surg | volume = 27 | issue = 2 | pages = 258-65 | month = Feb | year = 2005 | doi = 10.1016/j.ejcts.2004.11.003 | PMID = 15691679 }}</ref>
+*These procedures are less invasive than the Cox-Maze procedure and do not require a [[median sternotomy]] (vertical [[incision]] in the [[sternum]]) or [[cardiopulmonary bypass]] ([[heart-lung machine]]). The [[ablation]] lines are created using a variety of energy sources including [[radiofrequency]] energy, [[cryoablation]], and [[high intensity focused ultrasound]].<ref name="Khargi-2005">{{Cite journal  | last1 = Khargi | first1 = K. | last2 = Hutten | first2 = BA. | last3 = Lemke | first3 = B. | last4 = Deneke | first4 = T. | title = Surgical treatment of atrial fibrillation; a systematic review. | journal = Eur J Cardiothorac Surg | volume = 27 | issue = 2 | pages = 258-65 | month = Feb | year = 2005 | doi = 10.1016/j.ejcts.2004.11.003 | PMID = 15691679 }}</ref>
-Shortly thereafter, Randall K. Wolf, MD and others developed a procedure using radiofrequency energy rather than microwave, and different, slightly larger incisions.  In 2005, he published his results in the first 27 patients.<ref name="Wolf 2005">{{cite journal | author = Wolf R, Schneeberger E, Osterday R, Miller D, Merrill W, Flege J, Gillinov A | title = Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. | journal = J Thorac Cardiovasc Surg | volume = 130 | issue = 3 | pages = 797-802 | year = 2005 | id = PMID 16153931}}</ref>  This came to be known as the Wolf minimaze procedure.
+*Although Dr. Cox's 2004 definition specifically excludes an [[Epicardium|epicardial]] approach to eliminate [[atrial fibrillation]] ([[AF]]), he and others pursued this important goal, and the meaning of the term changed as successful [[Epicardium|epicardial]] procedures were developed. In 2002 Saltman performed a completely [[endoscopic]] surgical [[ablation]] of [[atrial fibrillation]] ([[AF]]) and subsequently published their results in 14 patients. <ref name="Saltman 2003"/><ref name="Salenger 2004">{{cite journal | author = Salenger R, Lahey S, Saltman A | title = The completely endoscopic treatment of atrial fibrillation: report on the first 14 patients with early results. | journal = Heart Surg Forum | volume = 7 | issue = 6 | pages = E555-8 | year = 2004 | id = PMID 15769685}}</ref>
+*These were performed [[Epicardium|epicardially]], on the beating [[heart]], without [[cardiopulmonary bypass]] or [[median sternotomy]]. Their method came to be known as the minimaze or microwave minimaze procedure, because microwave energy was used to make the [[lesions]] that had previously been performed by the [[surgery|surgeon's]] scalpel.
-Today, the terms “minimaze”, "mini-maze", and "mini maze" are still sometimes used to describe open heart procedures requiring cardiopulmonary bypass and median sternotomy, but are more commonly they refer to minimally invasive, epicardial procedures not requiring cardiopulmonary bypass, such as those developed by Saltman, Wolf, and others.  These procedures are characterized by:
+*Shortly thereafter, Randall K. Wolf, MD, and others developed a procedure using radiofrequency energy rather than microwave, and different, slightly larger [[incisions]]. In 2005, he published his results in the first 27 [[patients]]. This procedure came to be known as the Wolf minimaze procedure.<ref name="Wolf 2005">{{cite journal | author = Wolf R, Schneeberger E, Osterday R, Miller D, Merrill W, Flege J, Gillinov A | title = Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. | journal = J Thorac Cardiovasc Surg | volume = 130 | issue = 3 | pages = 797-802 | year = 2005 | id = PMID 16153931}}</ref>
+*Today, the terms “minimaze”, "mini-maze", and "mini maze" are still sometimes used to describe [[heart|open-heart]] procedures requiring [[cardiopulmonary bypass]] and [[median sternotomy]], but are more commonly they refer to minimally invasive, [[Epicardium|epicardial]] procedures not requiring [[cardiopulmonary bypass|cardiopulmonary bypasses]], such as those developed by Saltman, Wolf, and others. These procedures are characterized by:
-<blockquote>1. No median sternotomy incision; instead, an [[endoscope]] and/or “mini-thoracotomy” incisions between the ribs are used.<br>2. No cardiopulmonary bypass; instead, these procedures are performed on the normally beating heart.<br>3. Few or no actual incisions into the heart itself. The "maze" lesions are made epicardially by using radiofrequency, microwave, or [[ultrasonic]] energy, or by [[cryosurgery]].<br>4. The part of the left [[Atrium (heart)|atrium]] in which most clots form (the “appendage”) is usually removed, in an effort to reduce the long-term likelihood of [[stroke]].
+<blockquote>1. No [[median sternotomy]] [[incision]]; instead, an [[endoscope]] and/or “mini-[[thoracotomy]]” [[incisions]] between the [[ribs]] are used.<br>2. No [[cardiopulmonary bypass]]; instead, these procedures are performed on the normally beating [[heart]].<br>3. Few or no actual [[incisions] into the [[heart]] itself. The "maze" [[lesions]] are made [[Epicardium|epicardially]] by using radiofrequency, microwave, or [[ultrasonic]] energy, or by [[cryosurgery]].<br>4. The part of the left [[Atrium (heart)|atrium]] in which most [[Thrombus|clots]] form (the “[[appendage]]”) is usually removed, in an effort to reduce the long-term likelihood of [[stroke]].
 </blockquote>
 ====Microwave Minimaze====
-'''Completely Endoscopic Microwave Ablation of Atrial Fibrillation on the Beating Heart Using Bilateral Thoracoscopy:''' The microwave minimaze requires three 5 mm to 1cm incisions on each side of the chest for the surgical tools and the [[endoscope]].  The [[pericardium]] is entered, and two sterile rubber tubes are threaded behind the heart, in the transverse and oblique sinuses.  These tubes are joined together, then used to guide the flexible microwave antenna energy source through the sinuses behind the heart, to position it for [[ablation]].  Energy is delivered and the [[atrial]] tissue heated and destroyed in a series of steps as the microwave antenna is withdrawn behind the heart.  The lesions form a "box-like" pattern around all four [[pulmonary veins]] behind the heart.  The left atrial appendage is usually removed.<ref name="Saltman 2003">{{cite journal | author = Saltman A, Rosenthal L, Francalancia N, Lahey S | title = A completely endoscopic approach to microwave ablation for atrial fibrillation. | journal = Heart Surg Forum | volume = 6 | issue = 3 | pages = E38-41 | year = 2003 | id = PMID 12821436}}</ref><ref name="Salenger 2004"/>  A [http://www.ctsnet.org/sections/clinicalresources/adultcardiac/expert_tech-11.html very thorough description of the procedure] is available.
+'''Completely Endoscopic Microwave Ablation of Atrial Fibrillation on the Beating Heart Using Bilateral Thoracoscopy:''' <ref name="Saltman 2003">{{cite journal | author = Saltman A, Rosenthal L, Francalancia N, Lahey S | title = A completely endoscopic approach to microwave ablation for atrial fibrillation. | journal = Heart Surg Forum | volume = 6 | issue = 3 | pages = E38-41 | year = 2003 | id = PMID 12821436}}</ref><ref name="Salenger 2004"/>
+*The [[Microwave]] Minimaze requires three 5 mm to 1cm [[incisions]] on each side of the [[chest]] for the [[surgery|surgical tools]] and the [[endoscope]]. The [[pericardium]] is entered, and two sterile rubber tubes are threaded behind the [[heart]], in the transverse and oblique sinuses.
+*These tubes are joined together, then used to guide the flexible [[microwave]] antenna energy source through the sinuses behind the [[heart]], to position it for [[ablation]].  *Energy is delivered and the [[atrial]] [[Tissue (biology)|tissue]] heated and destroyed in a series of steps as the [[microwave]] antenna is withdrawn behind the [[heart]].
+*The lesions form a "box-like" pattern around all four [[pulmonary veins]] behind the [[heart]]. The [[Left atrium|left atrial appendage]] is usually removed.
+*A [http://www.ctsnet.org/sections/clinicalresources/adultcardiac/expert_tech-11.html very thorough description of the procedure] is available.
 ====Wolf Minimaze====
-'''Video-Assisted Bilateral Epicardial Bipolar Radiofrequency Pulmonary Vein Isolation and Left Atrial Appendage Excision:''' The Wolf minimaze requires one 5cm and two 1cm incisions on each side of the chest.  These incisions allow the surgeon to maneuver the tools, view areas through an [[endoscope]], and to see the heart directly.  The right side of the left [[Atrium (heart)|atrium]] is exposed first.  A clamp-like tool is positioned on the left [[Atrium (heart)|atrium]] near the right [[pulmonary veins]], and the [[atrial]] tissue is heated between the jaws of the clamp, cauterizing the area.  The clamp is removed.  The [[autonomic]] nerves (ganglionated plexi) that may cause [[AF]]<ref name="Coumel 1994">{{cite journal | author = Coumel P | title = Paroxysmal atrial fibrillation: a disorder of autonomic tone? | journal = Eur Heart J | volume = 15 Suppl A | issue = | pages = 9-16 | year = | id = PMID 8070496}}</ref> may be eliminated as well.  Subsequently the left side of the chest is entered.  The ligament of Marshall (a vestigial structure with marked [[autonomic]] activity) is removed.  The clamp is subsequently positioned on the left [[Atrium (heart)|atrium]] near the left [[pulmonary veins]] for [[ablation]].  Direct testing to demonstrate complete electrical isolation of the [[pulmonary veins]], and that the ganglionated plexi are no longer active, may be performed.<ref name="Wolf 2005"/>
+'''Video-Assisted Bilateral Epicardial Bipolar Radiofrequency Pulmonary Vein Isolation and Left Atrial Appendage Excision:''' <ref name="Coumel 1994">{{cite journal | author = Coumel P | title = Paroxysmal atrial fibrillation: a disorder of autonomic tone? | journal = Eur Heart J | volume = 15 Suppl A | issue = | pages = 9-16 | year = | id = PMID 8070496}}</ref><ref name="Wolf 2005"/>
+*The Wolf Minimaze requires one 5cm and two 1cm [[incision|incisions]] on each side of the [[chest]]. These [[incision|incisions]] allow the surgeon to maneuver the tools, view areas through an [[endoscope]], and see the [[heart]] directly.
+*The right side of the left [[Atrium (heart)|atrium]] is exposed first. A clamp-like tool is positioned on the left [[Atrium (heart)|atrium]] near the right [[pulmonary veins]], and the [[atrial]] [[Tissue (biology)|tissue]] is heated between the jaws of the clamp, cauterizing the area. Then the clamp is removed.
+*The [[autonomic]] [[nerve|nerves]] (ganglionated plexi) that may cause [[atrial fibrillation]] and may be eliminate it as well.
+*Subsequently the left side of the [[chest]] is entered.
+*The [[ligament]] of Marshall (a vestigial structure with marked [[autonomic]] activity) is removed. The clamp is subsequently positioned on the left [[Atrium (heart)|atrium]] near the left [[pulmonary veins]] for [[ablation]].
+*Direct testing to demonstrate complete electrical isolation of the [[pulmonary veins]], and that the ganglionated plexi is no longer active, may be performed.
 ====High Intensity Focused Ultrasound (HIFU) Minimaze====
-'''Surgical Ablation of Atrial Fibrillation with Off-Pump, Epicardial, High-Intensity Focused Ultrasound:''' Although the HIFU minimaze is performed epicardially, on the normally beating heart, it is also usually performed in conjunction with other [[cardiac surgery]], and so would not be minimally invasive in those cases.  An [[ultrasonic]] device is positioned epicardially, on the left [[Atrium (heart)|atrium]], around the [[pulmonary veins]], and intense acoustic energy is directed at the [[Atrium (heart)|atrium]] to destroy tissue in the appropriate regions near the [[pulmonary veins]].<ref name="Ninet 2005">{{cite journal | author = Ninet J, Roques X, Seitelberger R, Deville C, Pomar J, Robin J, Jegaden O, Wellens F, Wolner E, Vedrinne C, Gottardi R, Orrit J, Billes M, Hoffmann D, Cox J, Champsaur G | title = Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. | journal = J Thorac Cardiovasc Surg | volume = 130 | issue = 3 | pages = 803-9 | year = 2005 | id = PMID 16153932}}</ref>
+'''Surgical Ablation of Atrial Fibrillation with Off-Pump, Epicardial, High-Intensity Focused Ultrasound:''' <ref name="Ninet 2005">{{cite journal | author = Ninet J, Roques X, Seitelberger R, Deville C, Pomar J, Robin J, Jegaden O, Wellens F, Wolner E, Vedrinne C, Gottardi R, Orrit J, Billes M, Hoffmann D, Cox J, Champsaur G | title = Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. | journal = J Thorac Cardiovasc Surg | volume = 130 | issue = 3 | pages = 803-9 | year = 2005 | id = PMID 16153932}}</ref>
+*Although the HIFU minimaze is performed [[Epicardial|epicardially]], on the normally beating [[heart]], it is also usually performed in conjunction with other [[cardiac surgery]], and so would not be minimally invasive in those cases. An [[ultrasonic]] device is positioned [[Epicardial|epicardially]], on the left [[Atrium (heart)|atrium]], around the [[pulmonary veins]], and intense acoustic energy is directed at the [[Atrium (heart)|atrium]] to destroy [[Tissue (biology)|tissue]] in the appropriate regions near the [[pulmonary veins]].
 ===Mechanism of Elimination of Atrial Fibrillation===
-The mechanism by which [[AF]] is eliminated by curative procedures such as the maze, minimaze, or [[catheter ablation]] is controversial.  All successful methods destroy tissue in the areas of the left [[Atrium (heart)|atrium]] near the junction of the [[pulmonary veins]], hence these regions are thought to be important.  A concept gaining support is that paroxysmal [[AF]] is mediated in part by the [[autonomic nervous system]]<ref name="Coumel 1994">{{cite journal | author = Coumel P | title = Paroxysmal atrial fibrillation: a disorder of autonomic tone? | journal = Eur Heart J | volume = 15 Suppl A | issue = | pages = 9-16 | year = | id = PMID 8070496}}</ref> and that the intrinsic cardiac nervous system, which is located in these regions, plays an important role.<ref name="Scherlag 2006">{{cite journal | author = Scherlag B, Po S | title = The intrinsic cardiac nervous system and atrial fibrillation. | journal = Curr Opin Cardiol | volume = 21 | issue = 1 | pages = 51-4 | year = 2006 | id = PMID 16355030}}</ref>  Supporting this is the finding that targeting these autonomic sites improves the likelihood of successful elimination of [[AF]] by [[catheter ablation]].<ref name="Pappone 2004">{{cite journal | author = Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O | title = Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. | journal = Circulation | volume = 109 | issue = 3 | pages = 327-34 | year = 2004 | id = PMID 14707026}}</ref><ref name="Scherlag 2005">{{cite journal | author = Scherlag B, Nakagawa H, Jackman W, Yamanashi W, Patterson E, Po S, Lazzara R | title = Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. | journal = J Interv Card Electrophysiol | volume = 13 Suppl 1 | issue = | pages = 37-42 | year = 2005 | id = PMID 16133854}}</ref>
+*The mechanism by which [[atrial fibrillation]] is eliminated by curative procedures such as the maze, minimaze, or [[catheter ablation]] is controversial. <ref name="Coumel 1994">{{cite journal | author = Coumel P | title = Paroxysmal atrial fibrillation: a disorder of autonomic tone? | journal = Eur Heart J | volume = 15 Suppl A | issue = | pages = 9-16 | year = | id = PMID 8070496}}</ref>
+*All successful methods destroy [[Tissue (biology)|tissue]] in the areas of the left [[Atrium (heart)|atrium]] near the junction of the [[pulmonary veins]], hence these regions are thought to be important.
+*A concept gaining support is that paroxysmal [[atrial fibrillation]] is mediated in part by the [[autonomic nervous system]] and that the intrinsic [[Cardiac nerve|cardiac nervous system]], which is located in these regions, plays an important role.<ref name="Coumel 1994">{{cite journal | author = Coumel P | title = Paroxysmal atrial fibrillation: a disorder of autonomic tone? | journal = Eur Heart J | volume = 15 Suppl A | issue = | pages = 9-16 | year = | id = PMID 8070496}}</ref><ref name="Scherlag 2006">{{cite journal | author = Scherlag B, Po S | title = The intrinsic cardiac nervous system and atrial fibrillation. | journal = Curr Opin Cardiol | volume = 21 | issue = 1 | pages = 51-4 | year = 2006 | id = PMID 16355030}}</ref>
+*Targeting these [[Autonomic nervous system|autonomic sites]] improves the likelihood of successful elimination of [[atrial fibrillation]] by [[catheter ablation]].<ref name="Pappone 2004">{{cite journal | author = Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O | title = Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. | journal = Circulation | volume = 109 | issue = 3 | pages = 327-34 | year = 2004 | id = PMID 14707026}}</ref><ref name="Scherlag 2005">{{cite journal | author = Scherlag B, Nakagawa H, Jackman W, Yamanashi W, Patterson E, Po S, Lazzara R | title = Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. | journal = J Interv Card Electrophysiol | volume = 13 Suppl 1 | issue = | pages = 37-42 | year = 2005 | id = PMID 16133854}}</ref>
 ===Patient Selection===
+*The Minimaze procedures are alternatives to [[catheter ablation]] of [[atrial fibrillation]], and the [[patient]] selection criteria are similar.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
-The minimaze procedures are alternatives to [[catheter ablation]] of [[AF]], and the patient selection criteria are similar.  Patients are considered for minimaze procedures if they have moderate or severe symptoms and have failed medical therapy; asymptomatic patients are generally not considered.  Those most likely to have a good outcome have paroxysmal (intermittent) [[AF]], and have a heart that is relatively normal.  Those with severely enlarged [[atria]], marked [[cardiomyopathy]], or severely leaking [[heart valves]] are less likely to have a successful result; these procedures are generally not recommended for such patients.  Previous [[cardiac surgery]] provides technical challenges due to scarring on the outside of the heart, but does not always preclude minimaze surgery.
+*[[Patients]] are considered for Minimaze procedures if they have moderate or severe [[symptoms]] and have failed [[therapy|medical therapy]]; on the other hand [[symptom|asymptomatic]] [[patients]] are generally not considered.<ref name="pmid34020968">{{cite journal| author=Perry M, Kemmis Betty S, Downes N, Andrews N, Mackenzie S, Guideline Committee| title=Atrial fibrillation: diagnosis and management-summary of NICE guidance. | journal=BMJ | year= 2021 | volume= 373 | issue=  | pages= n1150 | pmid=34020968 | doi=10.1136/bmj.n1150 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34020968  }} </ref>
+*Those most likely to have a good outcome have paroxysmal (intermittent) [[atrial fibrillation]], and have a [[heart]] that is relatively normal.
+*Those with severely enlarged [[atria]], marked [[cardiomyopathy]], or severely leaking [[heart valves]] are less likely to have a successful result hence these procedures are generally not recommended for such [[patients]].
+*Previous [[cardiac surgery]] provides technical challenges due to [[scar|scarring]] on the outside of the [[heart]], but does not always preclude Minimaze [[surgery]].
 ===Surgical Results===
+*Long-term success of the Minimaze procedures awaits a consensus. Attaining a consensus is hindered by several problems; perhaps the most important of these is incomplete or inconsistent post-procedure follow-up to determine if [[atrial fibrillation]] has recurred.<ref name="Prasad 2003"/>
-Long-term success of the minimaze procedures awaits a consensus.  Attaining a consensus is hindered by several problems; perhaps the most important of these is incomplete or inconsistent post-procedure follow-up to determine if [[atrial fibrillation]] has recurred.<ref name="Prasad 2003"/>  It has been clearly demonstrated that longer or more intensive follow-up identifies much more recurrent [[atrial fibrillation]],<ref name="Israel 2004">{{cite journal | author = Israel C, Grönefeld G, Ehrlich J, Li Y, Hohnloser S | title = Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. | journal = J Am Coll Cardiol | volume = 43 | issue = 1 | pages = 47-52 | year = 2004 | id = PMID 14715182}}</ref> hence a procedure with more careful follow-up will appear to be less successful.  In addition, procedures continue to evolve rapidly, so long follow-up data do not accurately reflect current procedural methods.  For more recent minimaze procedures, only relatively small and preliminary reports are available.  A new metric ([http://www.minimaze.org/curativeprocedures.htm#SPRAS "Single Procedure Risk Adjusted Success"]) has been proposed in an attempt to control for some of these inconsistencies, but it has not been widely accepted.  With those caveats in mind, it can be said that reported short-term success rates range from 67% to 91%.<ref name="Salenger 2004"/><ref name="Wolf 2005"/><ref name="Ninet 2005"/>  Currently the limitation of ablation procedure deployed through a minimal access incision or port, constraints on the location and number of ablation lesions that can be performed.
+*It has been clearly demonstrated that longer or more intensive follow-up identifies much more recurrent [[atrial fibrillation]], hence a procedure with more careful follow-up will appear to be less successful.<ref name="Israel 2004">{{cite journal | author = Israel C, Grönefeld G, Ehrlich J, Li Y, Hohnloser S | title = Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. | journal = J Am Coll Cardiol | volume = 43 | issue = 1 | pages = 47-52 | year = 2004 | id = PMID 14715182}}</ref>
+*In addition, procedures continue to evolve rapidly, so long follow-up data do not accurately reflect current procedural methods. For more recent Minimaze procedures, only relatively small and preliminary reports are available.
+*A new metric ([http://www.minimaze.org/curativeprocedures.htm#SPRAS "Single Procedure Risk Adjusted Success"]) has been proposed in an attempt to control for some of these inconsistencies, but it has not been widely accepted. With those caveats in mind, it can be said that reported short-term success rates range from 67% to 91%.<ref name="Salenger 2004"/><ref name="Wolf 2005"/><ref name="Ninet 2005"/>
+*Currently the limitation of [[ablation]] procedure deployed through a minimal access [[incision]] or port, constraints on the location and number of [[ablation]] lesions that can be performed.
 ==2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary (DO NOT EDIT)<ref name="JanuaryWann2014">{{cite journal|last1=January|first1=Craig T.|last2=Wann|first2=L. Samuel|last3=Alpert|first3=Joseph S.|last4=Calkins|first4=Hugh|last5=Cleveland|first5=Joseph C.|last6=Cigarroa|first6=Joaquin E.|last7=Conti|first7=Jamie B.|last8=Ellinor|first8=Patrick T.|last9=Ezekowitz|first9=Michael D.|last10=Field|first10=Michael E.|last11=Murray|first11=Katherine T.|last12=Sacco|first12=Ralph L.|last13=Stevenson|first13=William G.|last14=Tchou|first14=Patrick J.|last15=Tracy|first15=Cynthia M.|last16=Yancy|first16=Clyde W.|title=2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary|journal=Journal of the American College of Cardiology|year=2014|issn=07351097|doi=10.1016/j.jacc.2014.03.021}}</ref>==
@@ Line 130: / Line 157: @@
 ==References==
 {{reflist|2}}
+{{WikiDoc Help Menu}}
+{{WikiDoc Sources}}
+[[CME Category::Cardiology]]
 [[Category:Cardiology]]
@@ Line 138: / Line 169: @@
 [[Category:Disease]]
 [[Category:Emergency medicine]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}


Atrial Fibrillation Microchapters
Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups Postoperative AF Acute Myocardial Infarction Wolff-Parkinson-White Preexcitation Syndrome Hypertrophic Cardiomyopathy Hyperthyroidism Pulmonary Diseases Pregnancy ACS and/or PCI or valve intervention Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram EKG Examples A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion Overview Electrical Cardioversion Pharmacological Cardioversion

Anticoagulation Overview Warfarin Converting from or to Warfarin Converting from or to Parenteral Anticoagulants Dabigatran

Maintenance of Sinus Rhythm

Surgery Catheter Ablation AV Nodal Ablation Surgical Ablation Cardiac Surgery
Specific Patient Groups

Primary Prevention
Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation surgical ablation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation surgical ablation

CDC on Atrial fibrillation surgical ablation

Atrial fibrillation surgical ablation in the news

Blogs on Atrial fibrillation surgical ablation

Directions to Hospitals Treating Atrial fibrillation surgical ablation

Risk calculators and risk factors for Atrial fibrillation surgical ablation